Deep brain stimulation (DBS) techniques for therapeutics were introduced in France in 1987. Since their inception a great deal of ongoing research has shed light into the potential applications of DBS to give people suffering from dystonia, Parkinson’s Disease, Tourette’s Syndrome, and Major Depressive Disorder, a chance at a better quality of life. In some cases, the DBS can be used to treat patients without the need for additional drugs that may carry a variety of side effects for individuals. More recently, DBS is also being considered for its potential to be used to put at bay Obsessive Compulsive Disorder (OCD), persons suffering overly from anxiety, among other applications. DBS requires biomedical engineers to work closely together with medical specialists and surgeons in the development of appropriate technology. DBS is not a cure, rather two electrodes (in the case of a bilateral implantation) are implanted in the brain (e.g. ventrointermediate nucleus (VIM) of the thalamus, globus pallidus internus or the subthalamic nucleus) and electric impulses sent to fend off overactivity. E.g. in the case of a patient who tremors, the stimulation helps them to stop tremoring by “zapping” that part of the brain responsible for the tremors. It follows then, for the patient who is feeling major depressive thoughts, the stimulation may help reduce periods of darkness. This is particularly the hope for those suffering from mental illness who seem to be drug resistant. Vagus Nerve Stimulation (VNS) acts in a similar way but instead of being embedded in the brain, the electrodes are placed in the vagus nerve, which is responsible for sending the mild pulses of electrical energy. A VNS sends continuous stimulation periodically, and is mainly used in those who suffer from epilepsy. There is now growing evidence to suggest that both DBS and VNS are having a positive impact on patients, but for some it has been proven to have no effect, or even a negative effect.
As the brain pacemaker industry becomes a multi-billion dollar industry, patient safety issues have entered the spotlight. The potential for infection, defective devices, devices that are misprogrammed, or even cyberhacking have received increasing attention. Some patients are now raising concerns about manufacturer discussions that devices should be linked to the Internet and what this might mean in the context of electromagnetic interference and the potential impact not only to render stimulators inoperable but the impact on the brain itself. Others hypothesise that if you can make corrections through stimulators, then you can also create problems with stimulators. How long might it be before DBS becomes a general purpose product possibly marketed for memory enhancement or use in defence contexts?
Neurosurgeon Robert Buchanan, MD, leads as chief of neurosurgery as well as director of epilepsy surgery and deep brain stimulation at the Seton Brain & Spine Institute in Austin, Texas. In this role, Dr. Robert Buchanan treats patients with Parkinson's disease and a variety of other movement disorders.
Delivery of electrical current to a specific subcortical grey matter target to stimulate a desired group of nerve cells which results in specific modulation the output of the involved neurocirciut.
Brain pacemakers is a medical device that is implanted into the brain to send electrical signals into the tissue. They are used to treat people who suffer from epilepsy, Parkinson's disease, major depression and other diseases. They have been working wonders with people who suffer from epilepsy, Parkinson’s disease, depression, and other diseases. With the placement of pacemakers in the brain, it may control or eliminate epileptic seizures with programmed or responsive stimulation. Also once the pacemaker is surgically put in the brain, electrical impulses are sent from the stimulator through the wires and into the brain. These impulses interfere with and block the electrical signals that cause disease symptoms. The electrical stimulation to the brain can also eliminate chronic depression if other treatments are not working. Pacemakers have, in a whole, improved the medical health field. New treatments, such as the deep brain stimulation for alzheimer's disease are being found.
Neurosurgeon Robert Buchanan, MD, leads as chief of neurosurgery as well as director of epilepsy surgery and deep brain stimulation at the Seton Brain & Spine Institute in Austin, Texas. In this role, Dr. Robert Buchanan treats patients with Parkinson's disease and a variety of other movement disorders.
Delivery of electrical current to a specific subcortical grey matter target to stimulate a desired group of nerve cells which results in specific modulation the output of the involved neurocirciut.
Brain pacemakers is a medical device that is implanted into the brain to send electrical signals into the tissue. They are used to treat people who suffer from epilepsy, Parkinson's disease, major depression and other diseases. They have been working wonders with people who suffer from epilepsy, Parkinson’s disease, depression, and other diseases. With the placement of pacemakers in the brain, it may control or eliminate epileptic seizures with programmed or responsive stimulation. Also once the pacemaker is surgically put in the brain, electrical impulses are sent from the stimulator through the wires and into the brain. These impulses interfere with and block the electrical signals that cause disease symptoms. The electrical stimulation to the brain can also eliminate chronic depression if other treatments are not working. Pacemakers have, in a whole, improved the medical health field. New treatments, such as the deep brain stimulation for alzheimer's disease are being found.
Deep brain stimulation (DBS)/Brain pacemaker has evolved as an important and established treatment modality for variety of advanced movement disorders and also for some psychiatry disorders.1Chronic DBS stimulation provides a non destructive and reversible means of disturbing the abnormal function of basal ganglia circuit. It can be adjusted as disease progresses or adverse event occur. Bilateral stimulation can be performed without a significant increase inadverse effects.Adverse events related to unintended stimulation of adjacent structures are readily reversible by altering the stimulus parameters.
This presentation describes the concept of temporal plus syndrome, pseudotemporal epilepsy and paradoxical temporal lobe epilepsy and how to differentiate them from temporal lobe epilepsy.
Magnets - Not Drugs: TMS IMMH San Antonio 2014Louis Cady, MD
In this talk, Dr. Cady covers a remarkable new treatment for depression: transcranial magnetic stimulation. The historical roots of this treatment are traced, followed by a review of the literature in terms of the proven efficacy of this treatment. A comparison with ECT shows that TMS has a very favorable profile, with remarkably fewer side effects and incredibly better tolerated side effects compared to ECT. Given that this was a "CME" talk, off-label uses of TMS were reviewed, including stepping stones for future avenues to explore
Deep brain stimulation (DBS)/Brain pacemaker has evolved as an important and established treatment modality for variety of advanced movement disorders and also for some psychiatry disorders.1Chronic DBS stimulation provides a non destructive and reversible means of disturbing the abnormal function of basal ganglia circuit. It can be adjusted as disease progresses or adverse event occur. Bilateral stimulation can be performed without a significant increase inadverse effects.Adverse events related to unintended stimulation of adjacent structures are readily reversible by altering the stimulus parameters.
This presentation describes the concept of temporal plus syndrome, pseudotemporal epilepsy and paradoxical temporal lobe epilepsy and how to differentiate them from temporal lobe epilepsy.
Magnets - Not Drugs: TMS IMMH San Antonio 2014Louis Cady, MD
In this talk, Dr. Cady covers a remarkable new treatment for depression: transcranial magnetic stimulation. The historical roots of this treatment are traced, followed by a review of the literature in terms of the proven efficacy of this treatment. A comparison with ECT shows that TMS has a very favorable profile, with remarkably fewer side effects and incredibly better tolerated side effects compared to ECT. Given that this was a "CME" talk, off-label uses of TMS were reviewed, including stepping stones for future avenues to explore
Beyond Brain on the Bench: Broader ImplicationsKatina Michael
This is an abridged version of a presentation delivered at the ARC ACES event during Science Week on the 19th August 2020. For the audio visit: https://www.katinamichael.com/seminars/2020/8/19/brain-on-the-bench-project
Microchipping People - The Risks (Engineers Australia)Katina Michael
There is nothing new about placing materials into the human body for prosthetic purposes. Since 1959 when an internal pacemaker was implanted into a patient, we have seen a proliferation of biomedical devices made from different chemical compositions (e.g. chromium, nickel, cobalt, titanium). Over this time, the implants have become much smaller in size, some manufacturers are even calling for their insertion into every human for personalised medicine. We hear that implants are now not only surgically placed in the heart or joints or ears, but since 1987 have made their debut also in the brain and retina. There are now a diverse range of use cases of passive implantable devices in the form of RF identification tags, marketed for multi-applications like identity tokens and physical access controllers. While we have a grasp of the known risks associated with biomedical devices, the risks associated with the open market of embedding microchips in voluntary participants is less understood.
Most do-it-yourselfer implantees will say: “if it’s good enough for my dog or cat, then it’s good enough for me”. Are the risks surrounding implantables (medical and non-medical) exaggerated or do we need further research to ascertain their short-term and long-term effects on the human body?
This presentation will discuss the risks associated with microchipping people for any reason, and will consider what the normalisation of biomedical devices for non-medical applications might mean in society at large in terms of risk.
See also: http://www.katinamichael.com/seminars/2018/3/8/microchipping-people-the-risks-ea-and-ieee-joint-lecture
Microchipping humans was once the stuff of science fiction but today we seem to be more than just dabbling in our dreams. For some fusing technology with the flesh will herald in an unforeseen utopia, and yet for others embedded sensors ‘under the skin’ is a clear marker of a dystopic future. What are the social implications of opting in or opting out to such a cyborgian vision? What are the unintended consequences of becoming an electrophorus? And what are the opportunity costs of not doing so? This presentation will describe where humans fit into The Internet of Things equation, and how we might be propelling ourselves toward an Internet of Us before too long. Welcome to uberveillance, where you too, might well be considered a node on a 5G network. It’s time to talk about the sociotechnical implications of humancentric embedded non-medical telecommunications devices that can be injected or even swallowed. More here also: http://www.katinamichael.com/seminars/2017/11/2/the-internet-of-us-radcomm2017
Artificial Intelligence in Biodiversity and Citizen ScienceKatina Michael
There’s little doubt that Artificial Intelligence has the potential to radically transform our world. Perhaps it's already doing so. In the fields of citizen science and biodiversity research, it offers some extraordinary opportunities - from the instant visual recognition of species to deep environmental insights generated out of big data analysis. These same developments also raise numerous questions about the impact A.I. will have on humanity and the natural environment. This workshop will examine the risks and opportunities presented by A.I. in the fields of citizen science and biodiversity. What are some of the key issues that researchers, practitioners, policy makers and the general public are or should be thinking about? More here: http://www.katinamichael.com/seminars/2017/10/31/examples-of-ai-in-biodiversitycitizen-science
Robots for Aged Care: Socio-ethical IssuesKatina Michael
This presentation will consider several use cases for robots in aged care. The audience will participate in raising socio-ethical issues of concern. These may be positions for robots to be used in aged care, or against robot use in aged care. For example, can robots help the elderly get out of bed, and get dressed? Might they make good companions to stave off loneliness or depression? Or might robots motivate the aged toward reaching news levels of fitness, instructing them in daily light aerobic activity? This presentation will discuss what we imagine robots to look like, whether or not robots are welcome by the ageing population, and what some of the risks might be if robots are considered a replacement for skilled people.
Importantly, the first 20 minutes of this talk will present an exclusive viewing of the film directed by Canadian Kim Trynacity titled: "Close Enough to Care." This has to be one of the most brilliant short documentaries I have seen on the topic.
Self authentication – is it possible or plausible?Katina Michael
Identification is changing rapidly today with the use of biometrics to facial recognition and other invasive technologies. We will explore if self-authentication is not only possible today but is it secure and safe?
Here, I will explore the whole idea of "self-authentication" which includes Biometrics, Facial Recognition, Microchip Implants and other sensory technology that banks are using and exploring. The session will explore the possibilities, and whether or not these possibilities are safe, secure and also ethical. Are they violating our privacy in ways we could never understand, inclusive of both intended and unintended consequences. Bitcoin and blockchain will come into the discussion.
Artificial Intelligence & Machine Learning. Is it Planet Saving Tech?Katina Michael
Depending on your framing, the coming age of Artificial Intelligence is either the panacea to all the worlds drudgery or heralds the arrival of our robot overloads and ultimate annihilation.
The truth is clearly somewhere in between, and depends a lot on a careful definition of terms, but either way the arrival of Artificial Intelligence and it’s subordinate cousins Machine & Deep Learning, presents a seismic shift and one which demands our immediate and focused attention.
Artificial Intelligence is here and it’s already doing interesting things, from influencing your Facebook feed to influencing US elections, from predicting your text messages to predicting where extreme weather events will hit, from recognising your voice to recognising endangered tigers.
And that’s just single purpose AI, stuff gets real when we begin to join a few of these ‘intelligences’ together, and Artificial General Intelligence emerges. AGI is still the realm if sci-fi, but for how long and what are the implications?
For the next Greenhouses evening we’ve approached a range of academics and thought-leaders to help us explore this fascinating topic, and help guide us as we decide how we can shape Artificial Intelligence and Machine Learning in to Planet Saving Technologies. More here:http://www.katinamichael.com/seminars/2017/9/26/artificial-intelligence-and-machine-learningas-emerging-technologies-in-social-and-environmental-impact and here: http://greenhouse.org.au/#event-2017-september
Repurposing Medical Implants: from Therapeutics to AugmentationKatina Michael
For over 55 years we have witnessed the development of heart pacemakers [1]. Incremental innovations have meant that this product technology has advanced as the industry surrounding it has created better componentry and connectivity. Once we considered the application of implantables for those who only desperately required it for life sustaining purposes, often as a last resort. Today, however, the emphasis is shifting from a restorative need to replace a human function that has been lost or degraded, to one that is preventative and takes on a guise of human augmentation. In all we are witnessing the rise of persuasive computing- that which not only acts as a tool or media, but also as a mechanism to change attitudes and behaviours of social actors through direct interaction or through a mediating role. For example, companies like Medtronics wish to implant sensors in everyone [2]. Their belief is to take the medical technology to the whole market, relying on a medical platform for non-medical control, care and convenience applications. The question is not whether we can achieve this technically, but whether answers to questions about ethics, culture and society can keep pace with rapid scientific advancements [3].
References:
[1] Catherine M. Banbury, 1997, Surviving Technological Innovation in the Pacemaker Industry, 1959-1990, Garland Publishing, Inc. New York.
[2] Eliza Strickland, 2014, Medtronic Wants to Implant Sensors in Everyone, IEEE Spectrum, http://spectrum.ieee.org/tech-talk/biomedical/devices/medtronic-wants-to-implant-sensors-in-everyone
[3] Roger Achille, Christine Perakslis, Katina Michael, 2013, “Ethical Issues to consider for Microchip Implants in Humans”, 7th International Conference on Ethical Issues In Biomedical Engineering, SUNY Downstate Medical Center, New York.
Presented "Repurposing Medical Implants from Therapeutics to Augmentation: the money is where the market is" August 19, 2016 at ACES Workshop on Wearables and Implantables. Innovation Campus, Wollongong, Australia. Panel theme: What We Have and Where We are Going?
The Benefits and Harms of National Security TechnologiesKatina Michael
This presentation was delivered by Katina Michael on 8 October 2015, as a keynote at the International Women in Law Enforcement Conference – Leadership, Collaboration & Security at SVP Police Academy, Hyderabad, India. More here: https://www.csu.edu.au/conference/policing
Methodological Approaches to Location-Based Social Networking ResearchKatina Michael
This tutorial was accepted into the 2017 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining. Conference location: Mercure Sydney, Australia, 31 July - 03 August, 2017. Presentation: 11am-1pm. Location based social networking (LBSN) is the convergence between location based services (LBS) and online social networking (OSN). LBSN applications offer users the ability to view and share location details with “friends” remotely, and in real-time, using a smart phone, desktop and/or other mobile devices. Users invite their friends to participate in LBSN and there is a process of consent that follows. LBSN tools essentially mesh together the positives and negatives of OSN and LBS, creating a unique domain of enquiry, thereby forcing researchers to ask new questions. While research in this field is heavily focussed on quantitative analysis and mining techniques, there is a lack of consideration of qualitative approaches to understanding LBSN applications, and the insights that can be garnered from the implementation of such techniques. This introductory tutorial offers alternative methodological approaches, which deliver rich, scenario-based outcomes that can be utilised to supplement existing quantitative techniques. More here: http://www.katinamichael.com/seminars/2017/7/30/methodological-approaches-to-location-based-social-networking-lbsn-research
This presentation will discuss the pros and cons of implantables at IEEE Sections Congress, August 11-13 2017, Sydney, Australia. The presentation will consider future applications of embedded devices and their social implications.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Deep Brain Stimulation for Therapeutics: What is the prognosis?
1. Deep Brain Stimulation: What is the Prognosis?
Katina Michael, Ph.D. (UOW), MTransCrimPrev (UOW), BIT (UTS)
@katinamichael #uberveillance #risk #harm #socialimplications #unintendedconsequences
2.
3. Deep Brain Stimulation
Deep Brain
Stimulation:
Sheila Cook has
electrodes
inserted in her
head to help with
her severe
depression
8. Anatomical Variability of the Cerebral Cortex
Schizophrenia Atlas Team: Narr & Thompson et al. A 3D map of variability is shown (above), on an average
surface Representation of the cortex derived from a schizophrenia (left) and normal control population
(right). Individual variations in brain structure, in frontal association areas (red colors), are greater in
schizophrenia. http://users.loni.usc.edu/~thompson/disease_atlases.html
16. rTMS (Transcranial Magnetic Stimulation)
• Electromagnetic induction using
an insulated coil placed over the
scalp
• Focused on an area of the brain
thought to play a role in mood
regulation
• Coil generates brief magnetic
pulses, which pass easily and
painlessly through the skull and
into the brain
http://www.hopkinsmedicine.org/psychiatry/specialty_areas/brain_stimulation/tms/
19. Vagus Nerve Stimulation (VNS)
• Stimulation of the nerve
responsible for relaying messages
between the brain and certain
parts of the body
• Does not require brain surgery
• Patient magnet offers additional
seizure control
• Holding the magnet over the
generator when you feel a seizure
coming on (or during a seizure), the
seizure may be stopped or
shortened in duration or intensity.
http://us.livanova.cyberonics.com/vns-therapy/how-vns-therapy-works
20.
21. “Buyer Beware”
Important Safety Information
• DBS can have serious if not fatal complications including coma,
bleeding inside the brain, seizures and infection.
• Once implanted the system may become infected, parts may wear
through the skin, and the lead, and/or extension connector may
move.
• The device could suddenly stop because of mechanical or electrical
problems.
• Any of these situations may require additional surgery or cause
symptoms to return.
* But these are plain vanilla issues of surgical implantation that are true for ANY implant.
22. Unintended Consequences
• Psychotic symptoms
• Auditory hallucinations
• Modifications in sleep patterns
• Uncontrolled and accidental stimulation of other parts of body
function
• Hypersexuality
• Hypomania
• Changes to heart and pulse rates
23. Humanitarian Device or Ultimate ESD
• One patient, as a result of a particular procedure in a DBS pilot study
described a sensation of “feeling hot, flushed, fearful, and panicky.”
• He could feel palpitations in his chest, and when asked indicated he
had an impending sense of doom.
• The feelings were coincident and continuous with the stimulator “on”
setting and they rapidly dissipated when switched off.
S. NA, et al., "Panic and fear induced by deep brain stimulation," J.
Neurol. Neurosurg Psychiatry, vol. 77, pp. 410–12, 2006.
J. Fins, et al., "Misuse of the FDA's humanitarian device
exemption in deep brain stimulation for obsessive-compulsive
disorder," Health Aff. (Millwood ), vol. 30, pp. 302–311, 2011.
24. DBS Therapy Off
Off Medication
DBS Therapy On
Off Medication
e this page has been amended to drive home a point about reverse engineering a perfectly normal person. It is a scenario ONLY.
http://americanhealthimaging.com/~ahi/wp-content/uploads/2014/12/equipment-banner.jpg
Magnetic Resonance of the Brain (MRI)
Services Provided
We provide comprehensive Neurological and Neurosurgical care under one practice.
Neurological Consultations: Diagnosis and treatment of common neurological diseases: Alzheimer's, Dementia, Strokes, Multiple Sclerosis, Brain Tumors, Peripheral Neuropathies, Myasthenia, Epilepsy, Parkinson's, Neck and Back pain, Headaches, Botox for headaches and spasticity.
Neurosurgical Consultations: Diagnosis and treatment of common neurosurgical disorders: BrainTumors, Pituitary tumors, Schwanomas, Surgical treatment of Spinal Disorders (Lower back and neck), Carpal Tunnel, Deep Brain Stimulator (DBS), Spinal Cord Implants.
Pediatric Neurology Consultations: Diagnosis and treatment of childhood neurology, epilepsy
http://www.neuroassociates.us/services-provided.html
A Bergonic chair, a device "for giving general electric treatment for psychological effect, in psycho-neurotic cases", according to original photo description. World War I era.
UNILATERAL PLACEMENT, BILATERAL PLACEMENT
There are primarily two types of electrode placements used for the delivery of ECT. Differences between these two techniques include the area of the brain stimulated, timing of response and potential side effects.
Right Unilateral Placement
To generate a seizure with a right unilateral treatment, one electrode is placed on the crown of the head and the other on the right temple. Those receiving the right unilateral treatments may respond somewhat more slowly than those who receive bilateral treatments. This difference is usually no greater than 1 to 2 treatments. Right unilateral treatment is typically associated with less memory side effects. Patients who do not respond to right unilateral treatments may require a switch to bilateral placement.
Bilateral Placement
Bilateral ECT treatment involves placing the electrodes on both temples. This treatment may be associated with more acute memory side effects than right unilateral treatments. Bilateral ECT is indicated for severe mental illnesses including depression with psychosis, manic episodes of bipolar disorder, psychosis related to schizophrenia and catatonia.
Why are we still using electroconvulsive therapy?
By Jim ReedBBC NewsnightThe use of electricity to treat mental illness started out as an experiment in the 1930s
Continue reading the main storyRelated Stories
ECT 'turns down brain connection'
The idea of treating a psychiatric illness by passing a jolt of electricity through the brain was one of the most controversial in 20th Century medicine. So why are we still using a procedure described by its critics as barbaric and ineffective?
Sixty-four-year-old John Wattie says his breakdown in the late 1990s was triggered by the collapse of his marriage and stress at work.
"We had a nice house and a nice lifestyle, but it was all just crumbling away. My depression was starting to overwhelm me. I lost control, I became violent," he explains.
John likens the feeling to being in a hole, a hole he could not get out of despite courses of pills and talking therapies.
But now, he says, all of that has changed thanks to what is one of the least understood treatments in psychiatry - electroconvulsive therapy (ECT).
"Before ECT I was the walking dead. I had no interest in life, I just wanted to disappear. After ECT I felt like there was a way out of it. I felt dramatically better."
The use of electricity to treat mental illness started out as an experiment. In the 1930s psychiatrists noticed some heavily distressed patients would suddenly improve after an epileptic fit.
Jump media player
Media player help
Out of media player. Press enter to return or tab to continue.
John Wattie on why he feels he needs ECT to keep severe depression at bay
Passing a strong electric current through the brain could trigger a similar seizure and - they hoped - a similar response.
By the 1960s it was being widely used to treat a variety of conditions, notably severe depression.
But as the old mental asylums closed down and aggressive physical interventions like lobotomies fell out of favour, so too did electroshock treatment, as ECT was previously known.
The infamous ECT scene in One Flew Over the Cuckoo's Nest cemented the idea in the public's mind of a brutal treatment, although by the time the film was released in 1975 it was very rarely given without a general anaesthetic.
Perhaps more significantly, new anti-depressant drugs introduced in the 1970-80s gave doctors new ways to treat long-term mental illness.
But for a group of the most severely depressed patients, ECT has remained one of the last options on the table when other therapies have failed.
Annually in the UK around 4,000 patients, of which John is one, still undergo ECT.
"It's not intuitive that causing seizures can be good for depression but it's long been determined that ECT is effective," says Professor Ian Reid at the University of Aberdeen, who heads up the team treating John.
ECT procedure (Warning: Some may find images upsetting)Continue reading the main storyA mouth guard is put between patient's teeth to prevent damage during shock and convulsions, and electrodes are applied to the temples. The electric shock is administered for about four seconds. Immediately afterwards the patient convulses for up to 60 seconds. On average patients convulse for 20 seconds.
Continue reading the main story
3/4
In the 75 years since ECT was first used scientists have argued about why and how it might work.
The latest theories build on the idea of hyperconnectivity. This new concept in psychiatry suggests parts of the brain can start to transmit signals in a dysfunctional way, overloading the system and leading to conditions from depression to autism.
Jump media player
Media player help
Out of media player. Press enter to return or tab to continue.
Helen Crane on how she forgot major events including her mother's death after ECT
Prof Reid and his colleagues used MRI scanners to map the brains of nine patients before and after treatment.
In an academic paper in 2012 they claimed ECT can "turn down" overactive connections as they start to build, effectively resetting the brain's wiring.
"For the first time we can point to something that ECT does in the brain that makes sense in the context of what we think is wrong in people who are depressed," Prof Reid says. "The change that we see in the brain connections after ECT reflects the change that we see in the symptom profile of patients who generally see a big improvement."
But passing electricity through the most complex organ in the body is not without risk. Many doctors think the side-effects of ECT can be so serious they outweigh any possible benefits.
Helen Crane was given two rounds of ECT in the late 1990s. She now blames the second course for wiping years of her memory, from trips abroad to dramatic family events.
"After ECT, I had this instinct that something was wrong with my mother. I said to my husband 'What's happened to my mother?' And then he had to tell me that she'd died nearly two years earlier," she says.
"It was devastating going through bereavement again. How on Earth could I have forgotten something so important and fundamental? Getting words wrong is frustrating, but to have lost really basic stuff in your life is awful."
Continue reading the main story“Start Quote
I'm convinced that in 10 or 15 years we will have put ECT in same rubbish bin of historical treatments as lobotomies and surprise baths that have been discarded over time”
Dr John ReadUniversity of Liverpool
Critics of ECT claim around a third of patients will notice some sort of permanent change from memory loss to problems with speech and basic skills like addition.
"What happens is a little like recharging a car battery," says the psychologist Dr John Read from the University of Liverpool, one of the most vocal critics of ECT.
"It's not difficult to get artificial changes in the brain, you could do it with cocaine, but it doesn't last and three or four weeks later the person is either back at the same level of depression or many studies show worse levels of depression."
Opponents say that ECT patients can enter into an addictive cycle of repeated treatment and that any improvement beyond the very short term is likely to be little more than an extreme form of the placebo effect, with patients benefitting psychologically from the extra care and medical attention associated with ECT.
"It's not in any way addressing the cause of their depression. It's systematically and gradually wiping out their memory and cognitive function," says Dr John Read.
"I'm convinced that in 10 or 15 years we will have put ECT in same rubbish bin of historical treatments as lobotomies and surprise baths that have been discarded over time."
Continue reading the main storyECT in the UK
Women are twice as likely to be given ECT as men, reflecting the general pattern of serious depression in society
Around a third of patients are too ill to give their consent
Across the UK as a whole it is thought around 4,000 people a year are given ECT
Scottish hospitals alone still treat 370 people a year, according to the latest figures.
But Prof Reid says when weighing up the risks and benefits of the treatment "it is important to realise that the people who are treated with ECT are suffering from an illness that could kill them".
"Depression is associated with a measurable mortality. It can be lethal. Untreated patients can die."
The team in Aberdeen now hope their research will allow drug companies to develop new treatments that mimic some of the effects of electroconvulsive therapy.
"One of the exciting things about being able to identify a change in the brain related to a psychiatric disorder is that it might make it easier to diagnose that condition over time," Prof Reid says.
"No one would be happier than me if we could reproduce the changes that ECT has on the brain in a less invasive and safer way for patients."
Transcranial Magnetic Stimulation (TMS) Service
http://www.hopkinsmedicine.org/psychiatry/specialty_areas/brain_stimulation/tms/
TMS is a non-invasive method of brain stimulation that relies on electromagnetic induction using an insulated coil placed over the scalp, focused on an area of the brain thought to play a role in mood regulation. The coil generates brief magnetic pulses, which pass easily and painlessly through the skull and into the brain. The pulses generated are of the same type and strength as those generated by magnetic resonance imaging (MRI) machines. When these pulses are administered in rapid succession, it is referred to as “repetitive TMS “ or “rTMS”, which can produce longer lasting changes in brain activity.
rTMS has been shown to be a safe and well-tolerated procedure that can be an effective treatment for patients with depression who have not benefitted from antidepressant medications or cannot tolerate antidepressant medications due to side-effects.
We offer rTMS at Johns Hopkins using the only TMS device approved by the FDA for the treatment of major depression. However, rTMS therapy is not appropriate for all patients. Before scheduling you for treatment, you must first be evaluated by one of our TMS psychiatrists to determine if rTMS would be safe and appropriate for you.
Lobotomies of the 1930s-1950s… Ice picks through http://www.delanceyplace.com/view-archives.php?p=2768